Genetic Markers and Personalized Risk Assessment

Understanding the hereditary and genetic factors behind lung health allows for customized screening protocols tailored to a person's unique profile. Scientists are mapping specific biomarkers that indicate elevated risk long before physical symptoms appear.

By supporting genetic epidemiology studies, we aim to refine predictive models used by clinicians worldwide. This proactive research ensures that preventive measures are targeted directly to those who will benefit the most.

Source: Supported by genetic epidemiology studies, Genome-Wide Association Studies (GWAS), and clinical genetics resources from institutions like The Jackson Laboratory and the National Cancer Institute.